ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8,901 | 79.27997 | 1 | female | 0 | 13 | 132 | COPD | COPD/CHF/Cirrhosis | 3 | 16 | null | 0 | 12,408 | 8,012.3398 | 7,965.19922 | 12 | white | 17.097656 | 19 | 0.736938 | 0.586914 | 1 | 0 | 0 | metastatic | 0.6 | 0.4 | no dnr | 13 | 59 | 6.099609 | 70 | 28 | 36.19531 | 176.1875 | 4.099609 | 0.799927 | 1 | 139 | 7.40918 | 113 | 14 | 800 | null | 3 | no(M2 and SIP pres) | 3 |
8,902 | 79.29596 | 1 | male | 0 | 13 | 123 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | null | 0 | 10,628 | 7,019.793 | 7,359.02734 | 7 | white | 27.796875 | 51 | 0.679932 | 0.510986 | 1 | 0 | 0 | no | 0.5 | 0.25 | no dnr | 13 | 53 | 15.898438 | 150 | 20 | 37.5 | 245 | 2.599609 | 0.399963 | 8.599609 | 140 | 7.219727 | 178 | 61 | 0 | 1 | 1 | no(M2 and SIP pres) | 1 |
8,903 | 61.465 | 1 | male | 0 | 43 | 376 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | $11-$25k | 44 | 137,058 | 91,445.5 | 97,328.6875 | 42.25 | white | 33.898438 | 54 | 0.309998 | 0.196991 | 18 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 43 | 82 | null | 62 | 16 | 35.89844 | null | null | null | 1.199951 | 140 | null | 139 | 18 | 4,500 | null | 0 | adl>=4 (>=5 if sur) | 0 |
8,904 | 50.54898 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 19,326 | 12,621.3359 | 10,800.1953 | 39 | white | 53.796875 | 90 | 0.125 | 0.056 | 3 | 0 | 0 | no | 0.05 | 0.02 | dnr after sadm | 3 | 104 | 7.299805 | 101 | 24 | 37.79688 | 266.625 | 3.699707 | 0.699951 | 1 | 135 | 7.479492 | 102 | 6 | 2,400 | null | null | <2 mo. follow-up | 2.104492 |
8,905 | 41.04898 | 1 | male | 0 | 18 | 111 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 12 | null | 0 | 21,882 | 15,987.7266 | 13,819.2656 | 16.333328 | white | 32.195313 | 65 | 0.768921 | 0.694946 | 1 | 1 | 0 | no | 0.9 | 0.85 | no dnr | 18 | 80 | 6.699219 | 48 | 16 | 35.59375 | null | null | 0.5 | 1.099854 | 138 | null | 125 | 13 | 2,125 | 0 | 5 | SIP>=30 | 5 |
8,906 | 53.41299 | 1 | male | 0 | 18 | 176 | Lung Cancer | Cancer | 1 | 14 | null | 0 | 18,409 | 12,327.4141 | 11,574.0391 | 8 | white | 16.898438 | 20 | 0.735962 | 0.467957 | 1 | 0 | 0 | metastatic | 0.6 | 0.4 | dnr after sadm | 1 | 119 | 14.5 | 100 | 20 | 36.5 | 128.5625 | 2.5 | 0.199982 | 3.5 | 133 | 7.459961 | 320 | 54 | 4,570 | 3 | 2 | adl>=4 (>=5 if sur) | 2 |
8,907 | 78.43896 | 1 | female | 0 | 18 | 300 | Lung Cancer | Cancer | 4 | 10 | under $11k | 0 | 7,898 | 5,355.1562 | 6,158.69922 | 5 | white | 15.199219 | 11 | 0.711914 | 0.430969 | 1 | 0 | 0 | metastatic | 0.9 | 0.4 | dnr before sadm | -1 | 114 | 14.099609 | 81 | 28 | 36.19531 | 237.03125 | null | null | 1.199951 | 146 | 7.449219 | 166 | 23 | 2,900 | 0 | null | no(M2 and SIP pres) | 0.494751 |
8,908 | 87.23895 | 0 | female | 0 | 5 | 577 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | null | 0 | 3,197 | 2,192.7578 | 2,027.46973 | 8 | white | 17.898438 | 31 | 0.813965 | 0.698975 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 5 | 112 | 5.299805 | 93 | 24 | 36.39844 | null | 4 | 0.399963 | 0.899902 | 134 | null | 254 | 9 | null | null | null | null | 2.452637 |
8,909 | 64.34998 | 1 | female | 0 | 14 | 20 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 20,747 | 13,424.3281 | 13,416.5781 | 12 | white | 28.5 | 60 | 0.507935 | 0.306946 | 1 | 0 | 0 | yes | 0.2 | 0.1 | dnr after sadm | 1 | 74 | 13.199219 | 98 | 24 | 35.59375 | 290.4375 | 3.699707 | 0.5 | 1 | 130 | 7.479492 | 126 | 17 | 1,125 | null | 2 | <2 mo. follow-up | 2 |
8,910 | 53.73297 | 1 | female | 1 | 3 | 3 | Coma | Coma | 0 | 12 | $11-$25k | 61 | 22,779 | 16,649.6875 | 18,364.8594 | 42 | white | 30.5 | 48 | 0.221985 | 0.158997 | 12 | 0 | 0 | no | null | null | dnr after sadm | 3 | 74 | 21.398438 | 60 | 8 | 38.69531 | 188 | 2.399902 | 1 | 1.799805 | 151 | 7.419922 | 243 | 63 | 3,300 | null | 0 | <2 mo. follow-up | 0 |
8,911 | 71.11597 | 1 | male | 1 | 17 | 17 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 10 | null | 26 | 17,697 | 12,093.5391 | 13,002.8672 | 17.333328 | white | 30 | 57 | 0.342957 | 0.154999 | 1 | 0 | 0 | no | 0.6 | 0.5 | dnr after sadm | 17 | 110 | 11.099609 | 108 | 32 | 37.79688 | null | 2.199707 | 1.5 | 0.899902 | 141 | null | 136 | 13 | 2,250 | null | 1 | <2 mo. follow-up | 1 |
8,912 | 66.29395 | 0 | female | 0 | 22 | 572 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | null | 0 | 58,552 | 40,298.8438 | 39,556.5938 | 37.666657 | white | 26.5 | 37 | 0.625 | 0.520996 | 14 | 0 | 0 | yes | 0.97 | 0.95 | no dnr | 22 | 56 | null | 110 | 10 | 36.39844 | 202.5 | null | 0.599976 | 1 | 137 | 7.429688 | 237 | 14 | 1,770 | null | 0 | no(M2 and SIP pres) | 0 |
8,913 | 54.91599 | 0 | male | 0 | 7 | 571 | COPD | COPD/CHF/Cirrhosis | 2 | 10 | null | 0 | 4,256 | 2,674.3203 | 2,640.37891 | 7 | white | 23.699219 | 25 | 0.870972 | 0.784912 | 1 | 0 | 0 | no | 1 | 0.9 | no dnr | 7 | 77 | 9.599609 | 128 | 32 | 38.19531 | null | 2.5 | 0.399963 | 0.899902 | 137 | null | 104 | 7 | null | 0 | 0 | null | 0 |
8,914 | 66.612 | 1 | female | 0 | 189 | 370 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 0 | 428,707 | null | null | 39.75 | white | 23.199219 | 47 | 0.748901 | 0.669922 | 17 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 189 | 107 | 5.5 | 106 | 32 | 38.39844 | 197.5 | 0.5 | 3.399902 | 1 | 139 | 7.389648 | 118 | 20 | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
8,915 | 71.59796 | 1 | female | 0 | 7 | 8 | Coma | Coma | 1 | 17 | $11-$25k | 9 | 8,412 | 5,682.4062 | 6,691.02734 | 5.5 | white | 24.699219 | 42 | 0.579956 | 0.513916 | 1 | 1 | 0 | no | 0.5 | 0.5 | dnr after sadm | 4 | 98 | 8.5 | 44 | 28 | 36.39844 | null | 4.199219 | 0.799927 | 1.699951 | 142 | null | 104 | 21 | 3,050 | null | 1 | <2 mo. follow-up | 1 |
8,916 | 71.90399 | 1 | male | 0 | 6 | 47 | Colon Cancer | Cancer | 1 | 13 | null | 0 | 10,473 | 6,775.8359 | 7,401.55859 | 12 | white | 25.199219 | 26 | 0.653931 | 0.348999 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | no dnr | 6 | 65 | 11.5 | 116 | 26 | 38.29688 | 124.4375 | 2.899902 | 0.699951 | 0.599976 | 133 | 7.529297 | 119 | 19 | 990 | 1 | 3 | <2 mo. follow-up | 3 |
8,917 | 71.72595 | 1 | female | 0 | 21 | 80 | Coma | Coma | 4 | 13 | $11-$25k | 9 | 43,394 | null | null | 21.666656 | white | 22 | 42 | 0.643921 | 0.583984 | 1 | 1 | 0 | no | 0.6 | 0.3 | dnr after sadm | 2 | 142 | 13.099609 | 64 | 28 | 35.69531 | 305 | 2.299805 | 0.299988 | 8.898438 | 134 | 7.519531 | 308 | 67 | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
8,918 | 71.409 | 1 | female | 0 | 5 | 7 | Lung Cancer | Cancer | 2 | 13 | null | 9 | 19,918 | 13,905.8516 | 14,534.5156 | 38 | white | 34.296875 | 40 | 0.181976 | 0.014999 | 1 | 0 | 0 | metastatic | 0.1 | 0.05 | dnr after sadm | 3 | 73 | 14.298828 | 150 | 22 | 35.69531 | 436 | 3.399902 | 0.799927 | 1 | 138 | 7.459961 | 94 | 12 | null | null | 5 | <2 mo. follow-up | 5 |
8,919 | 54.78998 | 1 | male | 0 | 6 | 28 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | under $11k | 0 | 7,798 | 5,192 | 6,066.23828 | 19 | white | 23.898438 | 27 | 0.839966 | 0.784912 | 1 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 6 | 117 | 0.299988 | 79 | 16 | 38.19531 | 578.25 | 3.599609 | 1.199951 | 1.299805 | 133 | 7.449219 | 88 | 30 | 2,100 | 0 | 4 | <2 mo. follow-up | 4 |
8,920 | 48.07898 | 1 | female | 1 | 5 | 5 | Coma | Coma | 1 | 12 | under $11k | 94 | 8,935 | 6,365.5859 | 6,481.04688 | 35 | white | 16.296875 | 30 | 0.544922 | 0.475952 | 1 | 0 | 0 | yes | 0.5 | 0.5 | dnr after sadm | 4 | 102 | 6.799805 | 67 | 24 | 36.19531 | null | 4.399414 | 0.599976 | 1.5 | 140 | null | 150 | 14 | null | null | 7 | <2 mo. follow-up | 7 |
8,921 | 76.71997 | 0 | male | 0 | 6 | 562 | COPD | COPD/CHF/Cirrhosis | 2 | 16 | null | 0 | 5,013 | 3,363.3359 | 3,150.13867 | 16 | white | 14.5 | 39 | 0.869995 | 0.783936 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 6 | 80 | 10.599609 | 114 | 32 | 35.69531 | 240 | 3.599609 | 0.5 | 1.099854 | 140 | 7.369141 | 124 | 25 | 875 | 0 | 1 | no(M2 and SIP pres) | 1 |
8,922 | 69.771 | 0 | male | 0 | 5 | 559 | Lung Cancer | Cancer | 1 | 12 | >$50k | 0 | 4,444 | 2,842.6035 | 2,263.41992 | 14 | white | 5.599609 | 9 | 0.865967 | 0.700928 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 57 | 16.898438 | 165 | 40 | 38.19531 | 280.75 | null | null | 1.299805 | 138 | 7.369141 | 274 | 32 | 1,250 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,923 | 68.64099 | 0 | female | 0 | 7 | 559 | CHF | COPD/CHF/Cirrhosis | 3 | 13 | $11-$25k | 0 | 6,748 | 4,771.9883 | 4,282.86719 | 8.5 | white | 22.398438 | 26 | 0.821899 | 0.709961 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 7 | 64 | 9.5 | 180 | 25 | 39.09375 | 185 | 1.599854 | 1.099854 | 0.899902 | 136 | 7.449219 | 74 | 24 | 1,500 | 2 | 1 | no(M2 and SIP pres) | 1 |
8,924 | 66.39294 | 1 | male | 0 | 3 | 81 | Lung Cancer | Cancer | 1 | 15 | $25-$50k | 0 | 3,660 | 2,215.7246 | 1,035.0293 | null | white | 15.199219 | 14 | 0.738892 | 0.471985 | 1 | 0 | 0 | metastatic | 1 | 0.9 | no dnr | 3 | 71 | 7.399414 | 114 | 29 | 38.89844 | 354.25 | null | null | 3.399902 | 137 | 7.399414 | 239 | 76 | 675 | 0 | null | null | 0.494751 |
8,925 | 75.409 | 0 | female | 0 | 4 | 558 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 2,968 | 1,964.3272 | 2,030.86914 | 6 | white | 16.097656 | 15 | 0.858887 | 0.767944 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 4 | 73 | 39.09375 | 128 | 24 | 35.69531 | 276 | null | 0.799927 | 0.699951 | 138 | 7.379883 | 227 | 18 | 1,900 | null | null | null | 2.818359 |
8,926 | 68.797 | 0 | female | 0 | 8 | 558 | COPD | COPD/CHF/Cirrhosis | 0 | 12 | null | 0 | 5,659 | 3,657.3691 | 4,326.84766 | 6 | white | 30.398438 | 31 | 0.679932 | 0.510986 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 8 | 69 | null | 83 | 20 | 36.09375 | 190.46875 | null | null | 1.699951 | 140 | 7.349609 | 83 | 26 | null | 1 | 0 | no(M2 and SIP pres) | 0 |
8,927 | 63.28299 | 1 | female | 0 | 10 | 256 | COPD | COPD/CHF/Cirrhosis | 4 | 10 | under $11k | 0 | 11,033 | 7,063.0547 | 7,416.25 | 17 | white | 18.097656 | 16 | 0.888916 | 0.814941 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 10 | 108 | 23.097656 | 104 | 24 | 35.5 | null | 3.199707 | 0.5 | 0.899902 | 132 | null | 113 | 9 | 5,050 | 2 | 4 | no(M2 and SIP pres) | 4 |
8,928 | 71.047 | 1 | male | 0 | 15 | 69 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 12,943 | 7,935.8086 | 10,164.8828 | 14.333328 | white | 17.398438 | 26 | 0.799927 | 0.574951 | 1 | 0 | 0 | metastatic | 0.2 | 0.5 | dnr after sadm | 2 | 71 | 9.199219 | 60 | 28 | 35.79688 | 268 | null | 0.5 | 1.099854 | 140 | 7.319336 | 118 | 10 | null | 1 | 1 | adl>=4 (>=5 if sur) | 1 |
8,929 | 68.84595 | 0 | female | 0 | 48 | 554 | Coma | Coma | 0 | 14 | null | 55 | 95,299 | 64,149.3125 | 64,849.8438 | 25 | white | 20.796875 | 13 | 0.365967 | 0.292969 | 22 | 0 | 0 | no | 0.1 | 0.5 | dnr after sadm | 2 | 105 | 24.398438 | 130 | 10 | 39.39844 | 132 | null | null | 4.699219 | 137 | 7.449219 | 139 | 123 | 955 | null | null | null | 1.866699 |
8,930 | 72.64294 | 0 | male | 0 | 7 | 555 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 6,267 | 4,345.1367 | 5,525.96875 | 4 | white | 23.597656 | 33 | 0.723999 | 0.569946 | 1 | 0 | 0 | yes | 0.85 | 0.5 | no dnr | 7 | 76 | 10.199219 | 101 | 28 | 36.19531 | 170.34375 | null | 0.399963 | 1 | 139 | 7.369141 | 173 | 28 | 2,500 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,931 | 76.56396 | 1 | male | 0 | 52 | 122 | MOSF w/Malig | ARF/MOSF | 2 | 8 | $11-$25k | 26 | 149,618 | 99,931.6875 | 106,433.312 | 41.75 | white | 28.097656 | 56 | 0.378967 | 0.259949 | 6 | 0 | 0 | yes | null | null | no dnr | 52 | 103 | 10.898438 | 57 | 24 | 36.29688 | null | null | 0.5 | 1.5 | 138 | null | 114 | 24 | 1,615 | null | 0 | no(M2 and SIP pres) | 0 |
8,932 | 56.76898 | 0 | female | 0 | 18 | 553 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | >$50k | 44 | 38,863 | 26,176.9688 | 27,202.0625 | 23.333328 | white | 16.796875 | 16 | 0.825928 | 0.766968 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 18 | 100 | 15 | 120 | 26 | 36.09375 | 253.3125 | null | null | 0.699951 | 131 | 7.459961 | 144 | 11 | 1,950 | null | 0 | no(M2 and SIP pres) | 0 |
8,933 | 71.26898 | 0 | male | 0 | 5 | 553 | Colon Cancer | Cancer | 1 | 10 | null | 0 | 3,105 | 2,058.2598 | 2,370.04883 | 8 | white | 16.398438 | 5 | 0.812988 | 0.598999 | 1 | 0 | 0 | metastatic | 0.75 | 0.5 | dnr after sadm | 1 | 79 | 9.398438 | 81 | 36 | 36.19531 | 196.65625 | null | 0.899902 | 1.299805 | 122 | 7.329102 | 163 | 19 | 1,300 | 0 | 0 | null | 0 |
8,934 | 78.89099 | 0 | male | 0 | 8 | 550 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 4,300 | 2,863.4453 | 2,517.21875 | 6.5 | white | 14.5 | 26 | 0.878906 | 0.797974 | 1 | 0 | 0 | no | null | null | dnr before sadm | -1 | 75 | 9.699219 | 104 | 24 | 35.69531 | 385.6875 | 2.599609 | 0.5 | 1.399902 | 125 | 7.469727 | 124 | 32 | 3,475 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,935 | 35.52899 | 0 | male | 0 | 10 | 550 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 9,998 | 6,636.9492 | 6,665.76953 | 13 | white | 22.796875 | 30 | 0.906982 | 0.843994 | 1 | 0 | 0 | no | null | null | no dnr | 10 | 33 | null | 76 | 20 | 38.59375 | 102.34375 | null | null | 4.199219 | 144 | 7.199219 | 235 | 70 | 330 | null | null | no(M2 and SIP pres) | 2.580566 |
8,936 | 74.74298 | 0 | male | 0 | 14 | 548 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 9 | 24,344 | 16,322.3438 | 14,694.75 | 14 | white | 25.296875 | 32 | 0.579956 | 0.469971 | 9 | 1 | 0 | yes | null | null | no dnr | 14 | 65 | 12 | 109 | 40 | 38.19531 | 177.5 | 2.5 | 1.199951 | 1.399902 | 134 | 7.489258 | 147 | 43 | 3,400 | null | null | null | 3.406738 |
8,937 | 75.96399 | 0 | male | 0 | 13 | 546 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | null | 0 | 44,512 | 30,112.0156 | 26,930.4062 | 29.5 | white | 16.597656 | 24 | 0.826904 | 0.767944 | 9 | 0 | 0 | no | null | null | no dnr | 13 | 110 | 11.599609 | 73 | 28 | 36 | 271.375 | null | 1.099854 | 1.5 | 142 | 7.529297 | 107 | 31 | 825 | null | 0 | no(M2 and SIP pres) | 0 |
8,938 | 81.81 | 1 | male | 1 | 109 | 109 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | null | 0 | 318,295 | 214,994.25 | 229,082.125 | 45.5 | white | 34.796875 | 43 | 0.286987 | 0.176971 | 15 | 0 | 0 | yes | 0.65 | 0.6 | no dnr | 109 | 105 | 15.199219 | 60 | 40 | 38.19531 | 286.625 | 2.899902 | 5.399414 | 4.5 | 137 | 7.449219 | 119 | 88 | 60 | null | 0 | adl>=4 (>=5 if sur) | 0 |
8,939 | 78.74597 | 1 | male | 1 | 4 | 4 | Coma | Coma | 0 | 17 | $25-$50k | 100 | 5,388 | 3,861.7012 | 4,002.45898 | 26 | white | 20 | 24 | 0.185974 | 0.127991 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 2 | 64 | 6.099609 | 81 | 28 | 35.79688 | 285.6875 | null | 0.399963 | 1.699951 | 136 | 7.479492 | 85 | 22 | 1,475 | null | null | <2 mo. follow-up | 2.433594 |
8,940 | 55.29599 | 0 | male | 0 | 12 | 544 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 19,255 | 12,978.9453 | 14,379.1641 | 27.5 | white | 22.898438 | 28 | 0.849976 | 0.797974 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 12 | 118 | 8.298828 | 79 | 24 | 36.29688 | 347.5625 | null | 0.799927 | 2.099609 | 138 | 7.429688 | 85 | 29 | 2,800 | null | 0 | no(M2 and SIP pres) | 0 |
8,941 | 68.56696 | 1 | male | 0 | 18 | 459 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 21,864 | 14,747.625 | 17,813.7188 | 20.666656 | white | 20.597656 | 37 | 0.841919 | 0.740967 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 18 | 105 | 6.399414 | 70 | 24 | 36.19531 | null | 3.799805 | 0.399963 | 1.5 | 138 | null | 125 | 25 | 1,050 | null | 3 | no(M2 and SIP pres) | 3 |
8,942 | 71.70697 | 1 | female | 0 | 6 | 129 | Lung Cancer | Cancer | 1 | 13 | null | 0 | 8,243 | 5,390.5586 | 6,000.4375 | 11 | white | 5.899414 | 21 | 0.860962 | 0.689941 | 1 | 0 | 0 | metastatic | 0.5 | 0.4 | no dnr | 6 | 109 | 7.599609 | 107 | 24 | 36.19531 | null | null | null | 1 | 138 | null | 132 | 6 | 4,150 | 0 | null | adl>=4 (>=5 if sur) | 0.494751 |
8,943 | 67.67694 | 1 | female | 0 | 5 | 6 | Lung Cancer | Cancer | 3 | 12 | null | 26 | 4,048 | 2,656.3848 | 2,981.67969 | 9 | white | 37.296875 | 21 | 0.068985 | 0.001 | 1 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 5 | 50 | 13.798828 | 65 | 30 | 36.29688 | 122.4375 | 2.899902 | 0.299988 | 1.599854 | 130 | 7.439453 | 249 | 34 | 1,375 | null | null | <2 mo. follow-up | 3.296875 |
8,944 | 69.06799 | 0 | male | 0 | 21 | 537 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 9 | $11-$25k | 0 | 57,387 | 38,371.0312 | 40,731.2188 | 19.666656 | white | 35.398438 | 51 | 0.47998 | 0.360962 | 6 | 1 | 0 | no | null | null | no dnr | 21 | 64 | 9.699219 | 150 | 12 | 39.29688 | 164.4375 | 1.399902 | 1.199951 | 0.599976 | 134 | 7.429688 | 140 | 6 | 3,390 | 1 | 2 | no(M2 and SIP pres) | 2 |
8,945 | 84.18298 | 0 | male | 0 | 7 | 538 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | null | 0 | 5,122 | 3,361.4199 | 2,794.32812 | 6 | white | 12.398438 | 21 | 0.855957 | 0.761963 | 1 | 0 | 0 | yes | null | null | no dnr | 7 | 62 | 19.597656 | 117 | 24 | 38.69531 | 190.90625 | null | null | 2.599609 | 130 | 7.379883 | 178 | 74 | 3,725 | 0 | 0 | null | 0 |
8,946 | 62.245 | 0 | female | 0 | 9 | 536 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 10,163 | 7,103.2852 | 6,540.81641 | 16 | white | 22.296875 | 32 | 0.751953 | 0.672974 | 1 | 1 | 0 | metastatic | 0.9 | 0.8 | no dnr | 9 | 53 | 15.298828 | 60 | 28 | 35.69531 | null | 3 | 0.5 | 1.699951 | 134 | null | 202 | 24 | null | 0 | 0 | SIP>=30 | 0 |
8,947 | 48.71698 | 0 | female | 0 | 8 | 534 | CHF | COPD/CHF/Cirrhosis | 5 | 11 | under $11k | 0 | 5,478 | 3,701.6191 | 3,353.34961 | 10 | white | 15.099609 | 9 | 0.932983 | 0.885986 | 1 | 1 | 0 | no | 0.95 | 0.95 | no dnr | 8 | 134 | 16.597656 | 113 | 12 | 38.59375 | 187.5 | 3.199707 | 0.199982 | 0.899902 | 132 | 7.5 | 209 | 25 | 2,100 | 2 | 2 | no(M2 and SIP pres) | 2 |
8,948 | 81.28998 | 0 | female | 0 | 7 | 532 | COPD | COPD/CHF/Cirrhosis | 3 | 15 | null | 0 | 4,894 | 3,127.5078 | 3,202.1582 | 4.5 | white | 25.398438 | 34 | 0.671997 | 0.500977 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 72 | 5.199219 | 74 | 16 | 36.59375 | 230.40625 | null | 0.399963 | 0.599976 | 143 | 7.389648 | 100 | 13 | 1,800 | 2 | 5 | adl>=4 (>=5 if sur) | 5 |
8,949 | 70.52698 | 0 | male | 0 | 5 | 533 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 5 | under $11k | 0 | 5,894 | 4,113.6797 | 4,046.45898 | 18 | white | 20.796875 | 45 | 0.791992 | 0.7229 | 1 | 1 | 0 | yes | null | null | no dnr | 5 | 73 | 19.296875 | 50 | 13 | 38.19531 | 177.125 | null | null | 1.599854 | 131 | 7.459961 | 117 | 28 | 1,690 | 1 | 0 | no(M2 and SIP pres) | 0 |
8,950 | 81.91394 | 0 | male | 0 | 5 | 531 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | null | 0 | 5,965 | 4,162.9961 | 4,471.95703 | 12 | white | 15.099609 | 20 | 0.86499 | 0.775879 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 65 | 8.699219 | 68 | 10 | 35.59375 | 240.21875 | 2.899902 | 1.199951 | 1 | 141 | 7.489258 | 153 | 22 | 1,725 | 1 | 1 | no(M2 and SIP pres) | 1 |
8,951 | 62.46997 | 1 | male | 0 | 11 | 265 | Colon Cancer | Cancer | 4 | 14 | null | 0 | 8,591 | 5,707.1836 | 4,523.44922 | 15 | white | 5.699219 | 14 | 0.92395 | 0.822998 | 1 | 1 | 0 | metastatic | null | null | no dnr | 11 | 65 | 6.299805 | 85 | 28 | 36 | 248 | null | null | 1.099854 | 138 | 7.399414 | 105 | 17 | 2,900 | 0 | 1 | no(M2 and SIP pres) | 1 |
8,952 | 67.47198 | 0 | male | 0 | 4 | 530 | Lung Cancer | Cancer | 1 | 8 | null | 0 | 2,660 | 1,693.166 | 1,980.0293 | 11 | white | 10.5 | 12 | 0.81189 | 0.595947 | 1 | 0 | 0 | metastatic | 1 | 0.99 | no dnr | 4 | 66 | 5.299805 | 83 | 16 | 36.19531 | null | 2.199707 | 0.899902 | 0.599976 | 137 | null | 109 | 11 | null | 0 | null | no(M2 and SIP pres) | 0.494751 |
8,953 | 58.448 | 1 | female | 1 | 16 | 16 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 13,341 | 8,917.6797 | 10,253.7891 | 10 | white | 16.898438 | 8 | 0.725952 | 0.451965 | 1 | 0 | 0 | metastatic | 0.7 | 0.6 | dnr after sadm | 13 | 71 | 24.296875 | 119 | 32 | 36.79688 | 171.40625 | 2.399902 | 6.599609 | 1.199951 | 136 | 7.349609 | 313 | 40 | 1,805 | 5 | 4 | <2 mo. follow-up | 4 |
8,954 | 68.76398 | 1 | female | 0 | 6 | 38 | COPD | COPD/CHF/Cirrhosis | 4 | 8 | under $11k | 9 | 3,837 | 2,528.0312 | 2,609.32812 | 4 | white | 29 | 55 | 0.67688 | 0.505981 | 1 | 0 | 0 | no | 0.3 | 0.2 | dnr before sadm | -1 | 136 | 7.899414 | 126 | 36 | 36.19531 | 233.3125 | null | 0.5 | 1.299805 | 140 | 7.379883 | 174 | 21 | 1,300 | null | 7 | <2 mo. follow-up | 7 |
8,955 | 67.05499 | 1 | male | 0 | 5 | 100 | Lung Cancer | Cancer | 2 | 18 | $25-$50k | 0 | 4,679 | 2,942.6231 | 3,030.74805 | 9 | white | 7.5 | 23 | 0.849976 | 0.667969 | 1 | 0 | 0 | metastatic | 0.8 | 0.7 | no dnr | 5 | 117 | 8.699219 | 59 | 16 | 35 | null | 3.599609 | 0.299988 | 0.5 | 138 | null | 108 | 9 | null | null | null | adl>=4 (>=5 if sur) | 1.831055 |
8,956 | 71.31598 | 0 | male | 0 | 21 | 527 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 41 | 98,932 | 67,951.6875 | 65,919.25 | 26 | white | 29.296875 | 57 | 0.411987 | 0.291992 | 10 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 21 | 95 | null | 83 | 24 | 35.59375 | null | 2 | 4.599609 | 1.299805 | 128 | null | 98 | 23 | 2,365 | null | 0 | no(M2 and SIP pres) | 0 |
8,957 | 65.336 | 1 | male | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 2 | 10 | under $11k | 44 | 61,342 | 40,270.5625 | 42,247.625 | 19 | white | 46 | 94 | 0.003 | 0 | 25 | 1 | 0 | yes | 0.1 | 0 | dnr after sadm | 2 | 115 | 19.5 | 68 | 28 | 38.19531 | 155 | null | null | 1.699951 | 131 | 7.30957 | 191 | 45 | 1,725 | null | null | <2 mo. follow-up | 2.552734 |
8,958 | 58.77899 | 1 | male | 1 | 4 | 4 | Coma | Coma | 0 | 12 | under $11k | 100 | 5,555 | 3,875.2422 | 4,022.19922 | 36 | white | 23.597656 | 41 | 0.278992 | 0.209991 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 2 | 88 | 8.898438 | 93 | 20 | 36.79688 | null | 4.099609 | 0.299988 | 0.899902 | 137 | null | 164 | 20 | 2,150 | null | null | <2 mo. follow-up | 2.28418 |
8,959 | 80.05499 | 1 | male | 0 | 4 | 50 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | $11-$25k | 0 | 2,719 | 1,778.9102 | 1,870.78906 | 6 | white | 27.898438 | 57 | 0.605957 | 0.416992 | 1 | 0 | 0 | yes | 0.95 | 0.8 | dnr before sadm | 0 | 127 | 8.099609 | 102 | 38 | 37.79688 | 138.75 | 3.099609 | 2.399902 | 1.699951 | 147 | 7.479492 | 164 | 32 | 3,325 | null | 1 | <2 mo. follow-up | 1 |
8,960 | 33.16599 | 1 | male | 0 | 7 | 35 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 11,651 | 7,486.0234 | 5,420.29688 | 7 | white | 21.796875 | 15 | 0.685913 | 0.393982 | 1 | 0 | 0 | metastatic | 1 | 0.5 | no dnr | 7 | 101 | 6.899414 | 112 | 24 | 36 | 280.9375 | null | 10.5 | 0.699951 | 141 | 7.519531 | 221 | 10 | 1,320 | null | 5 | <2 mo. follow-up | 5 |
8,961 | 62.86398 | 1 | female | 0 | 14 | 258 | COPD | COPD/CHF/Cirrhosis | 2 | 14 | null | 26 | 18,628 | 12,560 | 13,344.4688 | 17 | white | 21.199219 | 21 | 0.804932 | 0.685913 | 1 | 0 | 0 | no | null | null | no dnr | 14 | 68 | 8.699219 | 120 | 22 | 38.09375 | 93.875 | null | 0.399963 | 4.299805 | 134 | 7.15918 | 115 | 60 | 2,250 | null | 0 | no(M2 and SIP pres) | 0 |
8,962 | 68.16199 | 1 | male | 0 | 3 | 317 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | null | 0 | 2,142 | 1,490.7353 | 1,483.5293 | null | white | 19.5 | 32 | 0.85791 | 0.764893 | 1 | 1 | 0 | no | 0.6 | 0.6 | dnr after sadm | 1 | 67 | 11.798828 | 74 | 24 | 35.89844 | 233.3125 | 5.5 | 0.699951 | 0.899902 | 135 | 7.379883 | 111 | 10 | 2,300 | null | null | no(M2 and SIP pres) | 2.217285 |
8,963 | 64.17798 | 1 | male | 0 | 6 | 23 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | null | 0 | 9,287 | 6,525.3086 | 5,868.79688 | 19 | white | 20 | 14 | 0.839966 | 0.737915 | 4 | 0 | 0 | no | 0.4 | 0.25 | dnr after sadm | 2 | 109 | 9.898438 | 83 | 38 | 37.89844 | 212 | null | 1.199951 | 1.399902 | 137 | 7.519531 | 69 | 19 | 5,950 | null | null | <2 mo. follow-up | 1.903564 |
8,964 | 81.14697 | 0 | male | 0 | 9 | 522 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 7,115 | 4,636.8008 | 3,771.10938 | 7.5 | white | 25.5 | 20 | 0.717896 | 0.560913 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 9 | 78 | 13.5 | 118 | 28 | 38.69531 | 128 | 3.799805 | 0.399963 | 1.099854 | 138 | 7.439453 | 199 | 10 | 1,500 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,965 | 86.60095 | 1 | female | 1 | 9 | 9 | Coma | Coma | 1 | null | under $11k | 44 | 7,479 | 4,767.1875 | 4,794.17969 | 18 | white | 23.097656 | 51 | 0.296997 | 0.22699 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 135 | 18.398438 | 110 | 22 | 39.19531 | 251.40625 | 3.099609 | 0.599976 | 0.899902 | 123 | 7.509766 | 126 | 30 | 2,015 | null | 0 | <2 mo. follow-up | 0 |
8,966 | 75.19196 | 1 | female | 0 | 25 | 477 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 37 | 92,096 | 61,565.2812 | 64,428 | 26 | white | 28.796875 | 40 | 0.402954 | 0.283997 | 16 | 1 | 0 | no | 0.8 | 0.6 | no dnr | 25 | 108 | 9.798828 | 110 | 24 | 38.89844 | null | null | null | null | 140 | null | null | null | 850 | null | null | null | 2.845703 |
8,967 | 75.10699 | 1 | female | 0 | 7 | 35 | COPD | COPD/CHF/Cirrhosis | 4 | 16 | $25-$50k | 37 | 78,995 | null | null | 20 | white | 36.59375 | 48 | 0.184998 | 0.052994 | 6 | 1 | 0 | no | 0.7 | 0.6 | dnr after sadm | 5 | 71 | 30 | 136 | 24 | 38.89844 | 103.32812 | 2.299805 | 0.399963 | 1 | 148 | 7.399414 | 172 | 27 | 1,300 | null | 0 | <2 mo. follow-up | 0 |
8,968 | 62.44498 | 1 | male | 0 | 3 | 5 | Coma | Coma | 1 | 8 | null | 61 | 42,538 | 26,397.3906 | 29,676.4219 | null | white | 24.097656 | 38 | 0.302979 | 0.231995 | 21 | 0 | 0 | no | 0 | 0 | no dnr | 3 | 67 | 11.599609 | 57 | 56 | 38.39844 | 167.125 | 3 | 3.599609 | 2 | 132 | 7.30957 | 184 | 50 | 1,760 | null | 0 | <2 mo. follow-up | 0 |
8,969 | 63.90997 | 1 | male | 0 | 9 | 150 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 6,562 | 4,100.4648 | 4,156.77734 | 18 | white | 13.5 | 19 | 0.860962 | 0.689941 | 1 | 0 | 0 | metastatic | 0.7 | 0.4 | no dnr | 9 | 63 | 31.5 | 122 | 26 | 36.39844 | 89.32812 | null | null | 1.5 | 130 | 7.339844 | 151 | 57 | 623 | 7 | 5 | SIP>=30 | 5 |
8,970 | 68.92499 | 0 | male | 0 | 4 | 512 | COPD | COPD/CHF/Cirrhosis | 4 | 11 | null | 0 | 2,300 | 1,623.6016 | 1,594.26953 | 8 | white | 16.5 | 18 | 0.881958 | 0.802979 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 72 | 13.298828 | 68 | 10 | 36.59375 | 145 | null | null | 0.899902 | 142 | 7.40918 | 130 | 30 | 1,725 | null | 1 | no(M2 and SIP pres) | 1 |
8,971 | 72.19397 | 0 | female | 0 | 5 | 513 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 2,975 | 1,970.3672 | 2,313.56836 | 5 | white | 18 | 24 | 0.852905 | 0.757935 | 1 | 0 | 0 | no | 0.95 | 0.85 | no dnr | 5 | 64 | 9.398438 | 108 | 10 | 37.79688 | 187.5 | null | 0.299988 | 2 | 141 | 7.389648 | 94 | 43 | 1,100 | null | 0 | no(M2 and SIP pres) | 0 |
8,972 | 59.46899 | 1 | female | 0 | 71 | 87 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | null | 0 | 189,010 | 126,933.812 | 147,142.875 | 41 | white | 30.199219 | 52 | 0.666992 | 0.570923 | 1 | 0 | 0 | yes | null | null | no dnr | 71 | 109 | 20.898438 | 112 | 30 | 36 | 145.4375 | 2.799805 | 1.299805 | 1.099854 | 127 | 7.439453 | 243 | 15 | 4,985 | null | 1 | SIP>=30 | 1 |
8,973 | 65.15497 | 1 | female | 0 | 4 | 84 | Lung Cancer | Cancer | 2 | 8 | $25-$50k | 0 | 7,074 | 4,313.1484 | 4,095.1582 | 7 | white | 23.898438 | 6 | 0.545898 | 0.223999 | 1 | 0 | 0 | metastatic | 1 | 0.75 | dnr after sadm | 1 | 69 | 11.099609 | 69 | 20 | 35.79688 | null | 3.599609 | 1.799805 | 0.799927 | 132 | null | 153 | 16 | null | null | null | adl>=4 (>=5 if sur) | 2.400391 |
8,974 | 64.06799 | 1 | female | 0 | 5 | 166 | Lung Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 4,993 | 3,091.2793 | 2,519.34961 | 11 | white | 18.296875 | 23 | 0.68396 | 0.390991 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 5 | 114 | 13.099609 | 110 | 14 | 35.79688 | 153.3125 | null | null | 0.599976 | 138 | 7.439453 | 147 | 23 | 1,485 | null | null | null | 2.060547 |
8,975 | 66.05597 | 1 | female | 0 | 16 | 162 | Lung Cancer | Cancer | 2 | 12 | under $11k | 0 | 13,890 | 8,675.6484 | 8,634.39844 | 8 | white | 20.898438 | 18 | 0.618896 | 0.304993 | 1 | 0 | 0 | metastatic | 0.8 | 0.4 | no dnr | 16 | 105 | 7.599609 | 69 | 22 | 36.09375 | null | null | 0.899902 | 0.899902 | 144 | null | 107 | 9 | 5,525 | 0 | 3 | no(M2 and SIP pres) | 3 |
8,976 | 88.112 | 1 | female | 0 | 13 | 112 | CHF | COPD/CHF/Cirrhosis | 4 | 11 | under $11k | 0 | 9,488 | 6,267.2305 | 5,675.22656 | 12.5 | white | 11.699219 | 27 | 0.850952 | 0.754883 | 1 | 0 | 0 | yes | 0.75 | 0.75 | dnr after sadm | 1 | 64 | 5.799805 | 70 | 20 | 35.59375 | null | 4.299805 | 1.599854 | 1.399902 | 136 | null | 118 | 29 | 1,390 | 2 | 1 | adl>=4 (>=5 if sur) | 1 |
8,977 | 22.459 | 0 | female | 0 | 10 | 498 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | null | 0 | 15,931 | 10,389.1562 | 10,255.4688 | 18 | white | 27.796875 | 31 | 0.879883 | 0.837891 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 10 | 121 | 20.199219 | 115 | 28 | 38.89844 | 144 | 1.799805 | 1 | 0.599976 | 132 | 7.419922 | 157 | 28 | 2,595 | 1 | 6 | no(M2 and SIP pres) | 6 |
8,978 | 66.25098 | 1 | male | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 1 | 8 | null | 0 | 29,086 | 19,636.125 | 21,684.25 | 24.5 | white | 34.59375 | 54 | 0.362 | 0.243988 | 4 | 0 | 0 | yes | 0.3 | 0.2 | dnr after sadm | 1 | 99 | 8.898438 | 71 | 24 | 36.09375 | 233.3125 | null | 0.299988 | 2.799805 | 137 | 7.40918 | 174 | 46 | 1,325 | null | 5 | <2 mo. follow-up | 5 |
8,979 | 74.46698 | 0 | male | 0 | 7 | 493 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 5,049 | 3,338.9648 | 3,708.32812 | 6 | white | 18.398438 | 18 | 0.836914 | 0.733887 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr before sadm | -1 | 51 | null | 106 | 40 | 39.09375 | 92.5 | 3 | 0.699951 | 1.299805 | 132 | 7.479492 | 240 | 25 | 1,150 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,980 | 73.47595 | 0 | male | 0 | 12 | 491 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | null | 37 | 16,876 | 11,452.4375 | 11,882.0781 | 33.5 | white | 35.898438 | 49 | 0.29895 | 0.121994 | 1 | 0 | 0 | no | null | null | no dnr | 12 | 115 | 12 | 76 | 29 | 36.29688 | 223.3125 | null | null | 0.899902 | 135 | 7.349609 | 177 | 17 | 2,025 | null | 0 | no(M2 and SIP pres) | 0 |
8,981 | 66.24194 | 0 | female | 0 | 15 | 491 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 16 | $25-$50k | 0 | 14,301 | 9,458.6797 | 8,610.08594 | 11 | white | 17.097656 | 28 | 0.881958 | 0.839966 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 15 | 109 | 7.699219 | 110 | 20 | 36.19531 | null | 3.099609 | 0.299988 | 1.099854 | 139 | null | 74 | 11 | 3,250 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,982 | 71.49097 | 0 | female | 0 | 17 | 490 | COPD | COPD/CHF/Cirrhosis | 4 | null | null | 9 | 11,254 | 7,470.0898 | 7,097.4375 | 4 | white | 18.097656 | 33 | 0.796997 | 0.672974 | 1 | 1 | 1 | yes | null | null | dnr after sadm | 1 | 146 | 29.898438 | 152 | 44 | 38.79688 | 250 | 3 | 4.399414 | 1.799805 | 150 | 7.289062 | 368 | 56 | 1,400 | null | 0 | no(M2 and SIP pres) | 0 |
8,983 | 69.61298 | 0 | female | 0 | 5 | 489 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | null | 26 | 4,322 | 2,903.8184 | 3,324.76953 | 9 | white | 21.097656 | 35 | 0.608887 | 0.420959 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 5 | 57 | 10.298828 | 120 | 32 | 38.59375 | 250 | 2.299805 | 1 | 0.699951 | 136 | 7.349609 | 95 | 10 | 2,600 | null | 0 | no(M2 and SIP pres) | 0 |
8,984 | 78.61694 | 0 | male | 0 | 16 | 489 | CHF | COPD/CHF/Cirrhosis | 6 | 8 | $25-$50k | 0 | 15,164 | 9,715 | 11,443.1953 | 12 | white | 14.898438 | 45 | 0.875977 | 0.793945 | 1 | 1 | 0 | no | 0.9 | 0.7 | no dnr | 16 | 76 | 8.699219 | 60 | 22 | 35.5 | 220 | null | 0.699951 | 0.899902 | 144 | 7.289062 | 176 | 26 | 950 | 4 | 6 | adl>=4 (>=5 if sur) | 6 |
8,985 | 76.22498 | 0 | male | 0 | 16 | 487 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | null | 0 | 37,726 | 25,119.125 | 20,596.9375 | 20.333328 | white | 25.398438 | 44 | 0.674927 | 0.579956 | 9 | 0 | 0 | no | 0.8 | 0.6 | dnr before sadm | -8 | 71 | 10.898438 | 158 | 32 | 35.79688 | 244.4375 | 2.799805 | 0.5 | 2.199707 | 141 | 7.40918 | 144 | 49 | 2,550 | 0 | 1 | no(M2 and SIP pres) | 1 |
8,986 | 66.55396 | 1 | male | 0 | 12 | 290 | Colon Cancer | Cancer | 2 | 8 | null | 0 | 8,866 | 5,766.2461 | 6,733.52734 | 12.5 | white | 33.5 | 22 | 0.45697 | 0.143982 | 1 | 0 | 0 | metastatic | 0.5 | 0.25 | dnr after sadm | 2 | 67 | 0.5 | 102 | 24 | 37.79688 | 330 | 2.099609 | 0.599976 | 1.099854 | 142 | 7.419922 | 122 | 18 | 2,550 | null | null | adl>=4 (>=5 if sur) | 2.904297 |
8,987 | 65.56097 | 0 | male | 0 | 11 | 484 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | $11-$25k | 0 | 29,387 | 19,287.9688 | 20,213.2188 | 22.5 | white | 19.597656 | 39 | 0.848999 | 0.750977 | 3 | 1 | 0 | no | null | null | no dnr | 11 | 111 | 6.199219 | 107 | 24 | 38.79688 | null | 4.5 | 0.699951 | 1.5 | 136 | null | 110 | 25 | 2,150 | null | 0 | no(M2 and SIP pres) | 0 |
8,988 | 83.39496 | 0 | female | 0 | 49 | 485 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | null | 0 | 112,915 | 75,452.5 | 77,552.5 | 25.25 | white | 29.097656 | 45 | 0.541992 | 0.427979 | 10 | 0 | 0 | no | 1 | 0.9 | no dnr | 49 | 79 | 8.199219 | 67 | 24 | 37.89844 | 316 | 2.899902 | 0.199982 | 0.699951 | 138 | 7.419922 | 124 | 18 | 1,000 | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
8,989 | 67.35699 | 0 | male | 0 | 6 | 485 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 5,986 | 3,713.4238 | 4,657.53906 | 10 | white | 14.5 | 10 | 0.750977 | 0.490967 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 51 | 10 | 181 | 24 | 36.19531 | 356 | null | 0.599976 | 1.199951 | 133 | 7.469727 | 168 | 27 | 930 | 0 | null | no(M2 and SIP pres) | 0.494751 |
8,990 | 48.19998 | 0 | male | 0 | 5 | 482 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 26 | 5,518 | 3,836.4785 | 4,842.45703 | 18 | white | 20.296875 | 28 | 0.885986 | 0.809937 | 1 | 0 | 0 | no | 0.75 | 0.7 | dnr after sadm | 2 | 63 | 10 | 127 | 8 | 40.89844 | 155 | 2.5 | 1.5 | 3.699707 | 144 | 7.469727 | 108 | 72 | 1,510 | null | null | no(M2 and SIP pres) | 3.577637 |
8,991 | 59.95599 | 1 | male | 0 | 23 | 132 | MOSF w/Malig | ARF/MOSF | 2 | 20 | null | 0 | 48,649 | null | null | 33.666657 | white | 28.296875 | 61 | 0.517944 | 0.401978 | 10 | 0 | 0 | yes | 0.8 | 0.7 | no dnr | 23 | 41 | 14.798828 | 140 | 20 | 35.19531 | 88.75 | 2.399902 | 10.298828 | 1.099854 | 131 | 7.30957 | 94 | 23 | 350 | null | 0 | no(M2 and SIP pres) | 0 |
8,992 | 81.66699 | 0 | male | 0 | 33 | 482 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 41 | 96,173 | 61,584.6562 | 68,208.4375 | 23.5 | white | 16.796875 | 50 | 0.657959 | 0.559937 | 20 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 33 | 67 | 20.199219 | 74 | 28 | 35.39844 | 440 | 3 | 6.099609 | 4.899414 | 135 | 7.449219 | 154 | 50 | 175 | null | 0 | adl>=4 (>=5 if sur) | 0 |
8,993 | 78.05096 | 1 | female | 0 | 32 | 65 | Coma | Coma | 0 | 16 | null | 44 | 36,552 | 24,587.2344 | 26,509.6406 | 16.5 | white | 22 | 27 | 0.391968 | 0.317993 | 2 | 0 | 0 | no | 0.65 | 0.6 | dnr before sadm | -1 | 100 | 17 | 70 | 16 | 35.59375 | null | 4 | 0.5 | 1 | 127 | null | 276 | 21 | null | null | 0 | null | 0 |
8,994 | 72.87299 | 1 | male | 0 | 3 | 66 | Lung Cancer | Cancer | 1 | 8 | null | 0 | 4,081 | 2,483.1133 | 1,081.90918 | null | white | 18.5 | 12 | 0.656982 | 0.352966 | 1 | 0 | 0 | metastatic | 0.8 | 0.3 | no dnr | 3 | 79 | 11.699219 | 74 | 16 | 36.29688 | null | null | 0.199982 | 0.899902 | 140 | null | null | null | 3,300 | 0 | null | adl>=4 (>=5 if sur) | 0.494751 |
8,995 | 76.07697 | 1 | male | 0 | 13 | 18 | Lung Cancer | Cancer | 2 | 12 | $11-$25k | 9 | 12,127 | 7,949.0078 | 8,848.71875 | 17 | white | 24.898438 | 18 | 0.436951 | 0.127991 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 58 | 10.798828 | 69 | 20 | 36.39844 | 238.09375 | null | 0.399963 | 1.5 | 140 | 7.439453 | 108 | 32 | null | null | 0 | <2 mo. follow-up | 0 |
8,996 | 70.09198 | 1 | female | 0 | 13 | 77 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 9 | under $11k | 0 | 14,271 | 9,694.8438 | 12,627.375 | 20.5 | white | 29.097656 | 49 | 0.698975 | 0.608887 | 1 | 1 | 0 | no | 0.7 | 0.6 | dnr before sadm | -1 | 65 | 58.296875 | 70 | 24 | 36.19531 | null | 3.299805 | 2.199707 | 2.199707 | 128 | null | 103 | 57 | 370 | 6 | 3 | SIP>=30 | 3 |
8,997 | 87.45795 | 1 | male | 0 | 12 | 187 | COPD | COPD/CHF/Cirrhosis | 3 | 5 | under $11k | 0 | 7,245 | 4,796.3047 | 5,046.70703 | 4.5 | white | 18.199219 | 23 | 0.706909 | 0.545898 | 1 | 0 | 0 | yes | 0.95 | 0.9 | dnr after sadm | 1 | 47 | null | 150 | 10 | 38.69531 | 438.0625 | null | null | 0.699951 | 134 | 7.519531 | 158 | 19 | 1,175 | null | 0 | no(M2 and SIP pres) | 0 |
8,998 | 72.21594 | 1 | female | 0 | 5 | 144 | Colon Cancer | Cancer | 1 | 19 | null | 0 | 14,195 | 9,840.3594 | 10,359.6641 | 13 | white | 15.5 | 8 | 0.823975 | 0.618896 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 58 | 5.699219 | 123 | 32 | 39.29688 | null | 2 | 16.796875 | 1.199951 | 134 | null | 98 | 3 | null | null | null | adl>=4 (>=5 if sur) | 1.715576 |
8,999 | 71.69098 | 0 | male | 0 | 16 | 474 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 21,106 | 13,825.9844 | 14,169.8672 | 16.666656 | white | 21.398438 | 32 | 0.823975 | 0.713989 | 1 | 1 | 0 | no | null | null | no dnr | 16 | 101 | 19.699219 | 78 | 24 | 37.39844 | 180 | 2.099609 | 0.5 | 5 | 130 | 7.319336 | 98 | 61 | 1,570 | 0 | 0 | no(M2 and SIP pres) | 0 |
9,000 | 64.31195 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 41 | 29,670 | 19,539.4844 | 22,504.1406 | 34.5 | white | 19.398438 | 33 | 0.769897 | 0.695923 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 6 | 115 | 7.199219 | 130 | 28 | 35.69531 | 276 | null | null | 0.799927 | 143 | 7.429688 | 103 | 11 | 2,200 | null | 0 | <2 mo. follow-up | 0 |
Subsets and Splits